ATE396263T1 - Transgenes tiermodel für neurodegenerative erkrankungen - Google Patents

Transgenes tiermodel für neurodegenerative erkrankungen

Info

Publication number
ATE396263T1
ATE396263T1 AT00956461T AT00956461T ATE396263T1 AT E396263 T1 ATE396263 T1 AT E396263T1 AT 00956461 T AT00956461 T AT 00956461T AT 00956461 T AT00956461 T AT 00956461T AT E396263 T1 ATE396263 T1 AT E396263T1
Authority
AT
Austria
Prior art keywords
neurodegenerative diseases
transgenic animal
human
animal model
sequence
Prior art date
Application number
AT00956461T
Other languages
English (en)
Inventor
Hermann Luebbert
Original Assignee
Biofrontera Pharmaceuticals Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofrontera Pharmaceuticals Ag filed Critical Biofrontera Pharmaceuticals Ag
Application granted granted Critical
Publication of ATE396263T1 publication Critical patent/ATE396263T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT00956461T 1999-08-30 2000-08-18 Transgenes tiermodel für neurodegenerative erkrankungen ATE396263T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99116766A EP1081225A1 (de) 1999-08-30 1999-08-30 Transgenes Tiermodel für neurodegenerative Erkrankungen

Publications (1)

Publication Number Publication Date
ATE396263T1 true ATE396263T1 (de) 2008-06-15

Family

ID=8238860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956461T ATE396263T1 (de) 1999-08-30 2000-08-18 Transgenes tiermodel für neurodegenerative erkrankungen

Country Status (7)

Country Link
EP (2) EP1081225A1 (de)
JP (1) JP2003512026A (de)
AT (1) ATE396263T1 (de)
CA (1) CA2383564A1 (de)
DE (1) DE60038966D1 (de)
ES (1) ES2304973T3 (de)
WO (1) WO2001016176A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845245A1 (fr) * 2002-10-07 2004-04-09 Aventis Pharma Sa Modele animal de la maladie de parkinson
US6943278B2 (en) * 2002-10-15 2005-09-13 Genexel, Inc. Transgenic Drosophila having a disrupted Parkin gene and exhibits reduced climbing ability
JP7068973B2 (ja) * 2018-08-31 2022-05-17 株式会社 大昌電子 変位検出センサ組み込みプリント配線板装置およびその製造方法
CN113373150B (zh) * 2021-06-18 2022-11-22 南方科技大学 一种靶向dat基因的sgRNA及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998059050A1 (en) * 1997-06-25 1998-12-30 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Cloning of a gene mutation for parkinson's disease
AU2299999A (en) * 1998-02-09 1999-08-23 Yoshikuni Mizuno Dnas or genes participating in parkinson's disease
DE69941300D1 (de) * 1998-11-19 2009-10-01 Aventis Pharma Sa Fahren und verwendungen

Also Published As

Publication number Publication date
EP1208200A2 (de) 2002-05-29
EP1081225A1 (de) 2001-03-07
WO2001016176A3 (en) 2001-09-27
JP2003512026A (ja) 2003-04-02
CA2383564A1 (en) 2001-03-08
WO2001016176A2 (en) 2001-03-08
EP1208200B1 (de) 2008-05-21
ES2304973T3 (es) 2008-11-01
DE60038966D1 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
EP0778886A4 (de) Transgenes tier welches eine familiäre form vom menschlichen amyloiden vorläuferprotein exprimiert
IL154794A0 (en) Remedies for heart failure
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
WO2002047466A3 (en) Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
ATE445704T1 (de) Expressionsvektor für tierische zellen
WO2002005634A3 (en) Transgenic animal and methods
EP1029039A4 (de) Nichttransgenes tiermodell der alzheimer'schen krankheit
AU6090799A (en) Transgenic c. elegans as a model organism for research into alzheimer's disease
ATE396263T1 (de) Transgenes tiermodel für neurodegenerative erkrankungen
EP0981602A4 (de) Transgenes tier exprimierend nicht-natives wildtyp und familiäre alzheimer krankheit mutiertes presenilin-1 protein ohne ein hintergrundsniveau von nativen presenilin 1
HUP0003116A2 (hu) Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok
WO1998001549A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
DE69224327T2 (de) Nucleotidsequenzen
IL174726A (en) Non-human animals with transgenic nucleic acid encoded by a mutant perinylin 1 protein
WO2001002552A3 (en) Double transgenic animals as models for neurodegenerative disease
ATE490979T1 (de) Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
WO1998003643A3 (en) Transgenic animals with mutant human APP or A4CT sequences
FI951954A (fi) Transgeenisia eläimiä luuaineenvaihduntatautien malleina
EP1063298A3 (de) Transgenes Tiermodell für die Krankheit von Alzheimer
ATE336888T1 (de) Caspase 1 transgenes tier
DE60121324D1 (de) Tiermodel für neurodegenerative erkrankungen
FR2795739B1 (fr) Gene synthetique cryic et plantes transgeniques exprimant ledit gene
ATE497534T1 (de) Tier mit gen-hypoexpression
FR2827613B1 (fr) Acides nucleiques codant pour un polypeptide isum2a et utilisation de ces acides nucleiques pour l'obtention de plantes transformees produisant des graines affectees dans le developpement du germe
DE60044205D1 (de) Transgenes tier welches ein mehrfach-mutiertes presenilin-1 exprimiert

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties